Breaking News Instant updates and real-time market news.

PYPL

PayPal

$95.85

-1.55 (-1.59%)

, SYF

Synchrony

$34.88

-0.1 (-0.29%)

12:14
10/23/19
10/23
12:14
10/23/19
12:14

Fly Intel: What to watch in PayPal earnings report

PayPal (PYPL) is scheduled to report results of its third fiscal quarter after market close on October 23, with a conference call scheduled for 5:00 pm EDT. What to watch for: 1. OUTLOOK: During the company's last earnings call, PayPal said it sees third quarter earnings per share of 69c-71c and revenue between $4.33B-$4.38B. The company also said it sees 2019 EPS of $3.12-$3.17 and revenue of $17.6B-$17.8B. As previously disclosed, 2019 revenue growth guidance includes an expected decline of approximately 3.5 percentage points for full year 2019 related to the sale of U.S. consumer credit receivables portfolio to Synchrony (SYF). Earlier this month, PayPal said it expects to report a pre-tax loss of $228M, or $177M on an after-tax basis, on the company's strategic investments in the quarter ended September 30. The associated impact on earnings per diluted share for the quarter ended September 30, is estimated to be a negative 15c per share. 2. CHINESE PAYMENTS LICENSE: PayPal became the first foreign company to acquire a payments license in China after buying a majority stake in a Chine payments group, The Financial Times' Yuan Yang reported last month. The central bank approved PayPal's acquisition of a 70% stake in Guofubao, or GoPay, for an undisclosed amount, the author noted. Visa (V) and Mastercard (MA) are among those foreign companies that have been kept waiting for license approvals, despite rules in 2017 removing formal obstacles to market access. Commenting on the news, Canaccord analyst Joseph Vafi said that Paypal's disclosure of its controlling stake in Chinese payment player GoPay has material strategic implications longer term. The analyst noted the deal allowed PayPal to beat both Visa and Mastercard into the Chinese market and could be a conduit to drive meaningful cross-border payments volume allowing it to continue to sustain mid 20% payment volume for the next several years. 3. FACEBOOK'S LIBRA: Earlier this month, PayPal pulled out from the group of companies Facebook (FB) brought together to launch a global cryptocurrency-based payments network, the Wall Street Journal's Peter Rudegeair reported. The payments company "made the decision to forgo further participation"; in the group backing the Libra cryptocurrency, Rudegeair said, citing a PayPal spokesman in an email. 4. PARTNERSHIPS, NEW PRODUCTS: PayPal and Synchrony announced last week an expansion and extension of their strategic consumer credit relationship. As part of their expanded partnership, Synchrony will become the exclusive issuer of a Venmo co-branded consumer credit card in the U.S., which is expected to launch in the second half of 2020. PayPal and Synchrony also announced an extension of their overall consumer credit program relationship. Users will be able to apply, buy, and manage their account natively in the Venmo app. In addition, cardholders will receive real-time alerts and can interact in new ways including splitting and sharing purchases.

PYPL

PayPal

$95.85

-1.55 (-1.59%)

SYF

Synchrony

$34.88

-0.1 (-0.29%)

V

Visa

$171.35

0.46 (0.27%)

MA

MasterCard

$260.61

-0.69 (-0.26%)

FB

Facebook

$184.50

2.23 (1.22%)

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 21

    Nov

PYPL PayPal
$95.85

-1.55 (-1.59%)

10/10/19
NOMU
10/10/19
NO CHANGE
Target $139
NOMU
Buy
PayPal likely to sign more Chinese partnerships, says Nomura Instinet
On the heels of PayPal's recent GoPay acquisition, more partnerships with Chinese mobile payments players may be in the works, Nomura Instinet analyst Bill Carcache tells investors in a research note. The analyst believes the GoPay deal has raised the possibility of more "mutually beneficial partnerships" between PayPal and key players inside China's payments ecosystem. He keeps a Buy rating on the shares with a $139 price target.
10/09/19
BTIG
10/09/19
NO CHANGE
Target $130
BTIG
Buy
BTIG lowers Q3 EPS view for PayPal after projected investment losses
BTIG analyst Mark Palmer lowers his Q3 EPS view on Paypal to 54c from 69c after the company disclosed an expected 15c impact in the quarter from unrealized losses in its strategic investment portfolio. The analyst is keeping his Buy rating and $130 price target on the stock however, citing the company's "differentiated assets" and "trusted brand" sustaining its leading position in digital payments.
10/01/19
ADAM
10/01/19
NO CHANGE
Target $118
ADAM
Buy
PayPal payment processor deal beats card networks to China, says Canaccord
Canaccord analyst Joseph Vafi said Paypal's (PYPL) disclosure of its controlling stake in Chinese payment player GoPay has material strategic implications longer term. The analyst notes the deal allowed PayPal to beat both Visa (V) and Mastercard (MA) into the Chinese market and could be a conduit to drive meaningful cross-border payments volume allowing it to continue to sustain mid 20% payment volume for the next several years. Vafi reiterated his Buy rating and $118 price target on PayPal shares.
09/24/19
UBSW
09/24/19
NO CHANGE
Target $120
UBSW
Neutral
PayPal leads among P2P providers, app share remains stable, says UBS
UBS analyst Eric Wasserstrom is keeping his Neutral rating and $120 price target on PayPal as part of his broader research note into U.S. Payment Networks. The analyst states that his most recent UBS Evidence Lab Mobile Banking App Download data suggests that mobile payment apps continue to gain market share relative to the traditional banking apps, and within that category, remittance apps continue to lose share vs. P2P apps like Venmo. Wasserstrom adds that PayPal - while challenged by newer entrants like Square Cash - is still maintaining its leading position in P2P. The analyst maintains however that Venmo's contribution to PayPal's revenue and earnings is already reflected in the stock's premium multiple relative to its historical levels.
SYF Synchrony
$34.88

-0.1 (-0.29%)

08/16/19
DBAB
08/16/19
DOWNGRADE
Target $158
DBAB
Hold
Deutsche Bank downgrades Alliance Data on 'multiple potential headwinds'
Deutsche Bank analyst Ashish Sabadra downgraded Alliance Data Systems (ADS) to Hold from Buy and lowered his price target for the shares to $158 from $162. The analyst sees "multiple potential headwinds" for the company, including the reserve build, winding down portfolio held for sale, and declining interest rates weighing on earnings growth in 2020. The analyst points out that his 2020 earnings estimates are 10% below consensus. Alliance Data could continue to trade at a discount to Synchrony Financial (SYF) given its use of non-GAAP earnings and limited disclosures about consumer credit scores and revenue share, Sabadra tells investors in a research note.
08/20/19
RHCO
08/20/19
NO CHANGE
Target $160
RHCO
Buy
Alliance Data price target lowered to $160 from $180 at SunTrust
SunTrust analyst Andrew Jeffrey lowered his price target on Alliance Data (ADS) to $160 citing the risks around its uncertain portfolio composition from "repositioning of the book", rising credit costs in a recession, dilution from the potential Loyalty segment sale, and increased competition. The analyst is keeping his Buy rating on the Alliance Data stock however, saying its valuation is still at a 20% discount relative to its closest competitor Synchrony (SYF) which creates an "attractive" risk-reward.
09/11/19
NOMU
09/11/19
NO CHANGE
Target $43
NOMU
Buy
Synchrony price target raised to $43 from $39 at Nomura Instinet
Nomura Instinet analyst Bill Carcache raised his price target for Synchrony Financial to $43 from $39 saying his bullish outlook was reaffirmed in recent meetings with management. The analyst expects Synchrony to continue its upward trajectory through the rest of this year. He keeps a Buy rating on the shares.
09/24/19
MSCO
09/24/19
NO CHANGE
MSCO
Large-cap banks aren't gaining deposit market share, says Morgan Stanley
Morgan Stanley analyst Ken Zerbe said he continues to hear the "false narrative" that large-cap banks must be gaining market share due to their superior technology, but he insists they are not and that small and mid-cap banks have consistently gained deposit market share over the last five years. Individual large-cap banks that have had the biggest deposit share gains include Goldman Sachs (GS), Ally Financial (ALLY) and Synchrony Financial (SYF), while mid-cap banks that have delivered the biggest gains in share of total deposits include First Republic (FRC), KeyCorp (KEY) and Huntington (HBAN), Zerbe tells investors. Large-cap banks that have seen the largest declines in their respective individual shares of total deposits include JPMorgan (JPM), Wells Fargo (WFC) and Citigroup (C), while deposit share losers among mid-cap banks include Comerica (CMA), Prosperity Bancshares (PB) and Zions (ZION), said Zerbe.
V Visa
$171.35

0.46 (0.27%)

07/24/19
RAJA
07/24/19
NO CHANGE
Target $193
RAJA
Outperform
Visa price target raised to $193 from $177 at Raymond James
Raymond James analyst John Davis raised his price target for Visa to $193 from $177 following what he views as a "solid" Q3 print that included a top and bottom line beat, EPS guidance raise, and relatively stable quarter to date trends. The analyst reiterates an Outperform rating on the shares.
08/02/19
MSCO
08/02/19
NO CHANGE
Target $74
MSCO
Equal Weight
Square reported 'notable' deceleration in GPV, says Morgan Stanley
Morgan Stanley analyst James Faucette said the deceleration in gross payment volume, or GPV, growth reported by Square (SQ) this quarter was somewhat disappointing and "notable" given the strong U.S. consumer spending trends reported by other Payments players, including Visa (V) and MasterCard (MA). Combining this with the "deviation from Square's traditional beat-and-raise story" made him less positive about the report, although his calendar 2019 forecasts remain largely intact, said Faucette, who keeps an Equal Weight rating and $74 price target on Square shares.
09/13/19
RHCO
09/13/19
NO CHANGE
Target $325
RHCO
Buy
MasterCard price target raised to $325 from $310 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on MasterCard (MA) to $325 and kept his Buy rating, saying he expects the company to maintain its 10% or more EBITDA premium relative to Visa (V) and PayPal (PYPL). The analyst believes that MasterCard has a more durable organic revenue growth and offers a "differentiated competitive strategy" with its Real-Time Payments, adding that its monetization can be bolstered further by B2B products, cross-border payments, bill payments, point-of-sale technology, and other initiatives.
MA MasterCard
$260.61

-0.69 (-0.26%)

09/16/19
MSCO
09/16/19
NO CHANGE
Target $315
MSCO
Overweight
MasterCard price target raised to $315 from $291 at Morgan Stanley
Morgan Stanley analyst James Faucette raised his price target on MasterCard shares to $315 from $291 following the company's Investment Community Meeting last week. The intra-quarter data shared by the company should ease some near-term macro concerns and the event left him feeling confident in "the key pillars" of his Overweight thesis, Faucette tells investors. MasterCard is also making notable progress on its longer term initiatives, which should support growth beyond the company's 3-year outlook, added Faucette.
FB Facebook
$184.50

2.23 (1.22%)

10/15/19
JEFF
10/15/19
NO CHANGE
JEFF
Jefferies selective on Internet into Q3, most positive on Alphabet and Facebook
Jefferies analyst Brent Thill, who is "generally positive" on Internet sector fundamentals, tells investors to remain selective ahead of Q3 earnings. The analyst is most bullish on Alphabet (GOOGL), Facebook (FB), Expedia (EXPE), and Wix.com (WIX). He remains underweight TripAdvisor (TRIP), Shutterstock (SSTK), and Endurance (EIGI). Thill is most positive on Alphabet and Facebook. Alphabet's setup is better in the second half of the year relative to the first half due to easier comps, healthy core advertising, momentum in Google Cloud, and expanded hardware line-up ahead of the holidays, the analyst tells investors in a research note. He also likes Facebook's setup due to easier second half comps, recent product innovation on Instagram Commerce, and improvements to the core Facebook app. In e-commerce, Thill is a buyer of Amazon.com (AMZN) on any pullback. In travel, he like Expedia (EXPE) over Booking Holdings (BKNG). The analyst also views the recent selloff in Match Group (MTCH) shares as a buying opportunity.
10/16/19
BARD
10/16/19
NO CHANGE
Target $230
BARD
Outperform
Facebook checks generally positive but guidance could be overhang, says Baird
Baird analyst Colin Sebastian said Facebook will likely see upside to his and the Street's Q3 estimates as agency and advertiser checks suggest relatively steady growth rates versus the slowdown implied by guidance. The analyst believes the company's focus on privacy, data security, messaging , and other product improvements will continue to weigh on margins but he thinks it is likely embedded in investor expectations and consensus estimates. Sebastian reiterated his Outperform rating and $230 price target on Facebook shares.
10/22/19
KEYB
10/22/19
NO CHANGE
KEYB
Ad spending across major internet platforms remained healthy in Q3, says KeyBanc
KeyBanc analyst Andy Hargreaves says that despite signs of softness from large ad agencies, he believes ad spending across the major internet platforms remained healthy in Q3. The analyst expects positive results out of Facebook (FB) and results from Alphabet (GOOGL) that are largely in line with expectations. Feedback was more mixed around Twitter (TWTR), but not consistent enough to prompt a change to his estimates. Hargreaves continues to recommend owning Alphabet and Facebook.
10/23/19
MZHO
10/23/19
NO CHANGE
Target $247
MZHO
Buy
Facebook expense guidance will likely top consensus, says Mizuho
After hosting an investor call with a leading ad agency on Facebook's Q3 spending trends, Mizuho analyst James Lee says the company's expense guidance will likely be above consensus due to its data security initiatives. The analyst would be a buyer of Facebook shares on any weakness post guidance. He keeps a Buy rating on the name with a $247 price target.

TODAY'S FREE FLY STORIES

LMT

Lockheed Martin

$393.52

3.305 (0.85%)

17:39
11/15/19
11/15
17:39
11/15/19
17:39
Hot Stocks
Lockheed Martin awarded maximum $3.33B Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESCA

Escalade

$10.90

-0.09 (-0.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Escalade CEO Fetherman to retire »

Escalade announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$12.96

0.1 (0.78%)

, ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Eldorado, Caesars stockholders approve Eldorado acquisition of Caesars »

Eldorado Resorts (ERI)…

CZR

Caesars

$12.96

0.1 (0.78%)

ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EGRX

Eagle Pharmaceuticals

$57.24

0.55 (0.97%)

17:15
11/15/19
11/15
17:15
11/15/19
17:15
Syndicate
Breaking Syndicate news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

$60.82

0.84 (1.40%)

17:11
11/15/19
11/15
17:11
11/15/19
17:11
Hot Stocks
Fabrinet President Gill sells 12.9K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TEUM

Pareteum

$0.38

-0.0209 (-5.21%)

17:05
11/15/19
11/15
17:05
11/15/19
17:05
Hot Stocks
Pareteum receives noncompliance notice from Nasdaq »

Pareteum announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

Hexo

$1.78

-0.1 (-5.32%)

17:00
11/15/19
11/15
17:00
11/15/19
17:00
Hot Stocks
Hexo was cannabis was being grown in unlicensed space at Niagara site »

HEXO Corp provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$220.84

2.29 (1.05%)

, CELG

Celgene

$110.02

-0.01 (-0.01%)

16:57
11/15/19
11/15
16:57
11/15/19
16:57
Hot Stocks
Bristol-Myers gets FTC clearance for Celgene acquisition »

Bristol-Myers Squibb…

AMGN

Amgen

$220.84

2.29 (1.05%)

CELG

Celgene

$110.02

-0.01 (-0.01%)

BMY

Bristol-Myers

$58.61

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

RAVE

Rave Restaurant

$1.44

-0.79 (-35.43%)

16:47
11/15/19
11/15
16:47
11/15/19
16:47
Hot Stocks
BBRC Asset Management reports 6.6% passive stake in Rave Restaurant »

BBRC Asset Management …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHAP

Chaparral Energy

$0.89

-0.0521 (-5.52%)

16:46
11/15/19
11/15
16:46
11/15/19
16:46
Hot Stocks
Chaparral Energy receives continued listing standard notice from NYSE »

Chaparral Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

CI

Cigna

$196.08

6.41 (3.38%)

, CNC

Centene

$57.57

2.91 (5.32%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks closed out the…

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

NVDA

Nvidia

$204.12

-5.76 (-2.74%)

AMZN

Amazon.com

$1,739.33

-15.38 (-0.88%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

UAA

Under Armour

$17.78

0.65 (3.79%)

UA

Under Armour

$15.97

0.41 (2.64%)

AMRN

Amarin

$23.99

2.5 (11.63%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

GOOG

Alphabet

$1,334.01

21.82 (1.66%)

GOOGL

Alphabet Class A

$1,333.33

23.54 (1.80%)

ORCL

Oracle

$56.43

0.33 (0.59%)

RH

RH

$188.73

13.535 (7.73%)

QGEN

Qiagen

$40.56

3.255 (8.73%)

FTCH

Farfetch

$9.66

2.17 (28.97%)

THC

Tenet

$30.55

1.08 (3.66%)

TORC

resTORbio

$1.10

-6.83 (-86.13%)

ACB

Aurora Cannabis

$2.72

-0.57 (-17.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 28

    Dec

  • 06

    Jan

  • 21

    Jan

  • 06

    Feb

NYT

New York Times

$31.60

0.44 (1.41%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
New York Times CEO sells 66,000 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WEX

Wex

$200.52

4.61 (2.35%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
Wex director Morris sells 3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBLI

Cleveland BioLabs

$0.59

-0.0444 (-6.97%)

16:39
11/15/19
11/15
16:39
11/15/19
16:39
Hot Stocks
Cleveland BioLabs CEO resigns effective December 13th »

In a regulatory 8-K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGC

LogicBio Therapeutics

$9.29

-0.04 (-0.43%)

16:38
11/15/19
11/15
16:38
11/15/19
16:38
Syndicate
Breaking Syndicate news story on LogicBio Therapeutics »

LogicBio Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTBI

HomeTrust

$25.99

-0.31 (-1.18%)

16:38
11/15/19
11/15
16:38
11/15/19
16:38
Hot Stocks
HomeTrust raises quarterly dividend 17% to 7c per share »

HomeTrust Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

FR

First Industrial Realty

$42.05

-0.03 (-0.07%)

16:36
11/15/19
11/15
16:36
11/15/19
16:36
Hot Stocks
First Industrial Realty director sells 12K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBSI

United Bankshares

$39.51

-0.19 (-0.48%)

16:31
11/15/19
11/15
16:31
11/15/19
16:31
Hot Stocks
United Bankshares declares Q4 dividend of 35c per share »

United Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
11/15/19
11/15
16:30
11/15/19
16:30
Options
Preliminary option volume of 24.0M today »

Preliminary option volume…

16:25
11/15/19
11/15
16:25
11/15/19
16:25
Conference/Events
Federal Reserve Bank of San Francisco participates in a discussion »

San Francisco Federal…

GNLN

Greenlane

$3.36

-0.05 (-1.47%)

16:23
11/15/19
11/15
16:23
11/15/19
16:23
Hot Stocks
Greenlane CEO buys 56.4K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$91.89

-0.42 (-0.45%)

16:20
11/15/19
11/15
16:20
11/15/19
16:20
Syndicate
Breaking Syndicate news story on Arthur J. Gallagher »

Arthur J. Gallagher files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/15/19
11/15
16:17
11/15/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.